Ambuja Cements Limited (AMBUJACEM.BO)
AMBUJACEM.BO Stock Price Chart
Explore Ambuja Cements Limited interactive price chart. Choose custom timeframes to analyze AMBUJACEM.BO price movements and trends.
AMBUJACEM.BO Company Profile
Discover essential business fundamentals and corporate details for Ambuja Cements Limited (AMBUJACEM.BO) to support your stock research and investment decisions.
Sector
Basic Materials
Industry
Construction Materials
IPO Date
3 Jan 2000
Employees
3.55K
Website
https://www.ambujacement.comCEO
Vinod Mohanlal Bahety
Description
Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Mumbai, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.
AMBUJACEM.BO Financial Timeline
Browse a chronological timeline of Ambuja Cements Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 27 Jan 2026
Upcoming earnings on 29 Oct 2025
EPS estimate is ₹2.72, while revenue estimate is ₹92.51B.
Earnings released on 31 Jul 2025
EPS came in at ₹3.54 falling short of the estimated ₹31.50 by -88.76%, while revenue for the quarter reached ₹102.89B , beating expectations by +5.30%.
Dividend declared on 13 Jun 2025
A dividend of ₹2.00 per share was announced, adjusted to ₹2.00. The dividend was paid on 26 Jul 2025.
Earnings released on 29 Apr 2025
EPS came in at ₹3.33 falling short of the estimated ₹3.54 by -5.93%, while revenue for the quarter reached ₹98.89B , beating expectations by +63.72%.
Earnings released on 29 Jan 2025
EPS came in at ₹8.59 surpassing the estimated ₹3.20 by +168.44%, while revenue for the quarter reached ₹85.02B , beating expectations by +181.68%.
Earnings released on 28 Oct 2024
EPS came in at ₹2.48 surpassing the estimated ₹2.30 by +7.83%, while revenue for the quarter reached ₹75.16B , missing expectations by -9.22%.
Earnings released on 31 Jul 2024
EPS came in at ₹2.65 falling short of the estimated ₹4.68 by -43.38%, while revenue for the quarter reached ₹83.12B , beating expectations by +175.37%.
Dividend declared on 14 Jun 2024
A dividend of ₹2.00 per share was announced, adjusted to ₹2.00. The dividend was paid on 26 Jul 2024.
Earnings released on 1 May 2024
EPS came in at ₹3.83 falling short of the estimated ₹5.76 by -33.51%, while revenue for the quarter reached ₹88.94B , beating expectations by +194.67%.
Earnings released on 31 Jan 2024
EPS came in at ₹3.86 falling short of the estimated ₹4.56 by -15.35%, while revenue for the quarter reached ₹44.40B , beating expectations by +47.08%.
Earnings released on 31 Dec 2023
EPS came in at ₹3.86 surpassing the estimated ₹2.00 by +93.00%, while revenue for the quarter reached ₹81.29B , beating expectations by +96.85%.
Earnings released on 1 Nov 2023
EPS came in at ₹3.74 surpassing the estimated ₹3.04 by +23.03%, while revenue for the quarter reached ₹39.70B , beating expectations by +31.52%.
Earnings released on 30 Sept 2023
EPS came in at ₹3.74 surpassing the estimated ₹1.59 by +135.22%, while revenue for the quarter reached ₹74.24B , beating expectations by +109.15%.
Earnings released on 2 Aug 2023
EPS came in at ₹4.31 falling short of the estimated ₹5.78 by -25.43%, while revenue for the quarter reached ₹47.30B , beating expectations by +9.59%.
Dividend declared on 7 Jul 2023
A dividend of ₹2.50 per share was announced, adjusted to ₹2.50. The dividend was paid on 25 Jul 2023.
Earnings released on 30 Jun 2023
EPS came in at ₹4.31 , while revenue for the quarter reached ₹87.13B .
Earnings released on 2 May 2023
EPS came in at ₹3.78 surpassing the estimated ₹2.53 by +49.41%.
Earnings released on 30 Mar 2023
EPS came in at ₹3.08 falling short of the estimated ₹3.17 by -2.84%, while revenue for the quarter reached ₹79.66B , beating expectations by +104.88%.
Earnings released on 30 Dec 2022
EPS came in at ₹2.02 falling short of the estimated ₹2.73 by -26.01%, while revenue for the quarter reached ₹79.07B , beating expectations by +114.68%.
Earnings released on 30 Sept 2022
EPS came in at ₹0.47 falling short of the estimated ₹2.50 by -81.20%, while revenue for the quarter reached ₹71.43B , beating expectations by +126.27%.
Earnings released on 30 Jun 2022
EPS came in at ₹3.79 , while revenue for the quarter reached ₹80.33B .
Earnings released on 31 Mar 2022
EPS came in at ₹3.32 surpassing the estimated ₹3.07 by +8.14%, while revenue for the quarter reached ₹79.00B , beating expectations by +147.36%.
Dividend declared on 30 Mar 2022
A dividend of ₹6.30 per share was announced, adjusted to ₹6.30. The dividend was paid on 29 May 2022.
Earnings released on 31 Dec 2021
EPS came in at ₹1.46 , while revenue for the quarter reached ₹72.08B .
Earnings released on 30 Sept 2021
EPS came in at ₹3.35 , while revenue for the quarter reached ₹66.47B .
Earnings released on 30 Jun 2021
EPS came in at ₹4.41 , while revenue for the quarter reached ₹69.78B .
Earnings released on 31 Mar 2021
EPS came in at ₹4.77 , while revenue for the quarter reached ₹77.15B .
Dividend declared on 19 Mar 2021
A dividend of ₹1.00 per share was announced, adjusted to ₹1.00. The dividend was paid on 9 May 2021.
Earnings released on 31 Dec 2020
EPS came in at ₹3.69 , while revenue for the quarter reached ₹70.31B .
Dividend declared on 5 Nov 2020
A dividend of ₹17.00 per share was announced, adjusted to ₹17.00. The dividend was paid on 19 Nov 2020.
Earnings released on 30 Sept 2020
EPS came in at ₹3.13 , while revenue for the quarter reached ₹61.69B .
AMBUJACEM.BO Stock Performance
Access detailed AMBUJACEM.BO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.